adamantane has been researched along with Seizures in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gavzan, H; Ghanbari, E; Khoshkroodian, B; Sayyah, M | 1 |
| Gmiro, VE; Serdiuk, SE; Veselkina, OS | 1 |
| Gmiro, VE; Serdyuk, SE; Veselkina, OS | 1 |
| Mareš, P; Szczurowska, E | 1 |
| Balasubramaniam, A; Bertin, I; Bihel, F; Boon, P; Bourguignon, JJ; Buffel, I; Coppens, J; De Kock, J; De Prins, A; Hammoud, H; Humbert, JP; Maes, V; Massie, A; Meurs, A; Portelli, J; Schmitt, M; Simonin, F; Smolders, I; Tourwe, D; Utard, V; Vanhaecke, T | 1 |
| Ford, L; Rook, W; Vale, A | 1 |
| Abouchedid, R; Archer, JR; Dargan, PI; Dines, A; Ho, JH; Hudson, S; Wood, DM | 1 |
| Borea, PA; Canazza, I; De Luca, MA; Di Rosa, F; Fantinati, A; Gregori, A; Margiani, G; Marti, M; Ossato, A; Rimondo, C; Serpelloni, G; Trapella, C; Varani, K; Vincenzi, F | 1 |
| Efremov, OM; Gmiro, VE; Serdyuk, SE | 1 |
| Lukomskaia, NIa; Magazanik, LG; Vataev, SI; Zhabko, EP | 1 |
| Bol'shakov, KV; Gmiro, VE; Gorbunova, LV; Lukomskaia, NIa; Magazanik, LG; Rukoiatkina, NI | 1 |
| Bol'shakov, KV; Gmiro, VE; Gorbunova, LV; Lukomskaya, NY; Magazanik, LG; Rukoyatkina, NI | 1 |
| Antonov, SM; Gmiro, VE; Johnson, JW; Lukomskaia, NIa; Magazanik, LG; Potap'eva, NN | 1 |
| Iinuma, K; Murakami, K; Onodera, K; Watanabe, T; Yokoyama, H | 1 |
| Bentley, DW; Betts, RF; Karki, SD | 1 |
15 other study(ies) available for adamantane and Seizures
| Article | Year |
|---|---|
Anti-Seizure Activity of 1-Adamantane Carboxylic Acid in Common Experimental Seizure Models: Role of Benzodiazepine-GABAA Receptors.
Topics: Adamantane; Amygdala; Animals; Anticonvulsants; Benzodiazepines; Disease Models, Animal; Electroshock; Kindling, Neurologic; Male; Mice; Neuroprotective Agents; Neurotoxins; Pentylenetetrazole; Rats, Wistar; Receptors, GABA-A; Seizures; Time Factors | 2021 |
[Combined blockade of AMPA- and NMDA-receptors has maximum effect to eliminate development of pentylenetetrazole-induced kindling in rats].
Topics: Adamantane; Administration, Oral; Animals; Anticonvulsants; Drug Administration Schedule; Male; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate; Seizures; Severity of Illness Index; Valproic Acid | 2013 |
Combined blockade of NMDA and AMPA receptors prevents acute kainate seizures and chronic kainate lethality in rats.
Topics: Adamantane; Amines; Animals; Anticonvulsants; Convulsants; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Injections, Intramuscular; Kainic Acid; Male; Memantine; N-Methylaspartate; Neuroprotective Agents; Pentylenetetrazole; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Seizures; Survival Analysis | 2014 |
An antagonist of calcium permeable AMPA receptors, IEM1460: Anticonvulsant action in immature rats?
Topics: Adamantane; Animals; Anticonvulsants; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Electrodes, Implanted; Electroencephalography; Male; Pentylenetetrazole; Rats, Wistar; Receptors, AMPA; Seizures | 2015 |
Neuropeptide FF receptors as novel targets for limbic seizure attenuation.
Topics: Adamantane; Animals; Anticonvulsants; Arginine; CHO Cells; Cricetulus; Dipeptides; Disease Models, Animal; HEK293 Cells; Humans; Limbic System; Male; Pilocarpine; Rats, Wistar; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Seizures | 2015 |
Four analytically confirmed cases of use of third-generation synthetic cannabinoid receptor agonists incorporating an adamantyl group.
Topics: Adamantane; Cannabinoid Receptor Agonists; Consciousness; Diazepam; Humans; Prisoners; Seizures; Tachycardia | 2016 |
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Topics: Adamantane; Administration, Intravenous; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Citalopram; Female; Fluoxetine; Hallucinations; Hallucinogens; Humans; Indazoles; Indoles; Lysergic Acid Diethylamide; Midazolam; Psychomotor Agitation; Quinolines; Seizures; Tachycardia; Time Factors; Young Adult | 2016 |
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Topics: Adamantane; Aggression; Animals; Behavior, Animal; Binding, Competitive; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabis; Catalepsy; Dopamine; Dronabinol; Humans; In Vitro Techniques; Indazoles; Indoles; Male; Mice; Motor Activity; Naphthalenes; Nucleus Accumbens; Pain Threshold; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Abnormal; Seizures | 2016 |
Peripheral and central routes of administration of quaternary ammonium compound IEM-1460 are equally potent in reducing the severity of nicotine-induced seizures in mice.
Topics: Adamantane; Animals; Biguanides; Male; Mice; Nicotine; Receptors, AMPA; Receptors, Nicotinic; Seizures | 2008 |
[Effects of ionotropic glutamate receptor channel blockers on the development of audiogenic seizures in Krushinski-Molodkina rats].
Topics: Acoustic Stimulation; Adamantane; Animals; Cyclohexylamines; Diamines; Drug Administration Schedule; Epilepsy, Reflex; Excitatory Amino Acid Antagonists; Injections, Intramuscular; Male; Memantine; Motor Activity; Quaternary Ammonium Compounds; Rats; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Seizures | 2012 |
[Comparison of the anticonvulsant activity of organic mono- and di-cations and their potential to inhibit NMDA and AMPA glutamate receptors].
Topics: Adamantane; Animals; Anticonvulsants; Brain; Cations; Convulsants; Diamines; Disease Models, Animal; In Vitro Techniques; Male; Mice; Neurons; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Seizures | 2002 |
Comparison of the anticonvulsive activities of organic mono- and dications with their abilities to inhibit NMDA and AMPA glutamate receptors.
Topics: Adamantane; Animals; Anticonvulsants; Brain; Cations, Divalent; Cations, Monovalent; Convulsants; Diamines; Kainic Acid; Male; Mice; N-Methylaspartate; Neurons; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Seizures | 2004 |
[The blockade of glutaminergic and cholinergic ion channels by adamantane derivatives].
Topics: Adamantane; Animals; Cells, Cultured; Cerebral Cortex; Diptera; Drug Evaluation, Preclinical; In Vitro Techniques; Ion Channels; Larva; Mice; N-Methylaspartate; Neuromuscular Junction; Neurons; Rana temporaria; Rats; Receptors, Cholinergic; Receptors, Glutamate; Seizures; Structure-Activity Relationship; Synaptic Transmission | 1994 |
AQ-0145, a newly developed histamine H3 antagonist, decreased seizure susceptibility of electrically induced convulsions in mice.
Topics: Adamantane; Amidines; Animals; Anticonvulsants; Histamine Antagonists; Imidazoles; Male; Mice; Seizures | 1995 |
Rimantadine and seizures.
Topics: Adamantane; Adult; Aged; Aged, 80 and over; Anticonvulsants; Humans; Influenza, Human; Male; Rimantadine; Seizures | 1989 |